Research Article
Clinical Features, Diagnosis, and Treatment Strategies of Gastrointestinal Diaphragm Disease Associated with Nonsteroidal Anti-Inflammatory Drugs
Table 2
Type of NSAIDs used in patients with NSAIDs-induced DD.
| NSAIDs | () |
| Traditional NSAIDs | 121 (84.0%) | Diclofenac | 47 (32.6%) | Aspirin | 36 (25.0%) | Indomethacin | 22 (15.3%) | Ibuprofen | 20 (13.9%) | Naproxen | 11 (7.6%) | Paracetamol | 7 (4.9%) | Azapropazone | 5 (3.5%) | Phenylbutazone | 4 (2.8%) | Loxoprofen | 4 (2.8%) | Sulindac | 3 (2.1%) | Selective COX-2 inhibitor | 38 (26.4%) | Piroxicam | 16 (11.1%) | Rofecoxib | 7 (4.9%) | Meloxicam | 5 (3.5%) | Celecoxib | 4 (2.8%) | Etodolac | 4 (2.8%) | Nabumetone | 2 (1.4%) | Tenoxicam | 1 (0.7%) | Nimesulide | 1 (0.7%) | Other | | Compound aminopyrine phenacetin | 1 (0.7%) |
|
|